Quality development only£2,421 Safety development only£2,421 Quality and safety development£3,367 Clinical development only£3,039 Quality and clinical development£3,986 Safety and clinical development£3,986 Quality, safety and clinical development£4,936 Discussion on development of paediatric forms and uses meeting criteria for waiver set down in schedule 5 paragraph 10 of SI 2008 No.552No fee
Pre-consultation application meetings on devices incorporating an ancillary medicinal substance*  Quality development only£824 Safety development only£824 Quality and safety development£1,044 Clinical development only£1,044 Quality and clinical development£1,429 Safety and clinical development£1,429 Quality, safety and clinical development£1,813 Broader scope meetings£4,896 Pharmacovigilance advice meetings  Standard meeting£3,367 Major meeting£3,986 Post-authorisation regulatory advice meetings£3,039 Advertising advice£2,421 Advice on labels and leaflets£2,421 Reclassification advice meetings  Pharmacy to General Sales List switch£3,039 Prescription Only Medicine to Pharmacy switch£3,986 *Scientific advice on the medicinal substance aspects of the device product.